The ultimate solution for aortic diseases
Aortyx has raised $16.0M in total funding. The most recent round was Series A. The last funding was announced in June 2025.
Aortyx's investors include European Innovation Council, Clave, Capital Cell, European Innovation Council Fund, CDTI Innovacion's INNVIERTE program.
Aortyx is headquartered in Barcelona, Spain.
The ultimate solution for aortic diseases
Aortyx is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aortyx — Funding & Investors." VCBacked, June 12, 2025, https://www.vcbacked.co/company/aortyx. Accessed July 20, 2026.
VCBacked. (2025). Aortyx — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/aortyx
{{cite web |title=Aortyx — Funding & Investors |url=https://www.vcbacked.co/company/aortyx |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated